Enterprise Europe Network

COVID-19: Polish SME offers to test antiviral properties of products and materials under the outsourcing agreement

Country of origin:
Country: 
POLAND
Opportunity:
External Id: 
BOPL20200708002
Published
15/07/2020
Last update
26/07/2021
Expiration date
26/07/2022

Keywords

Partner keyword: 
Virus, Virology/Antibiotics/Bacteriology
Analyses / Test Facilities and Methods
Diagnostic services
Process control and logistics
Textiles (synthetic and natural)
Packing products and systems
Manufacture of construction materials, components and systems
Research and experimental development on biotechnology
EXPRESS YOUR INTEREST

Summary

Summary: 
A Polish company from the biotechnology sector has developed a method of testing antiviral properties of materials such as fabrics, polymers, biomaterials. They are using special combinations of bacteriophages (small agents that infect and kill bacteria) to determine whether the given material inhibits the development of viruses. The firm is interested in cooperation under an outsourcing agreement.

Description

Description: 

A biotech SME from northwestern Poland was founded in 2018 by two bioengineers with an academic background. So far they've been working with bacteriophages, providing domestic and foreign partners (i.a. Germany, France, UK) with custom-made solutions for dealing with bacterial pathogens. Against the backdrop of COVID-19 pandemic caused by the SARS-Cov-2 virus, the company has found a new application for its technology. With their unique collection of over 900 phages, they can and are offering to test the antiviral properties of materials such as fabrics, polymers, biomaterials.

The company has been successfully providing this innovative service to a foreign partner, and now would like to enable other companies to test materials they are using and make their products safer for their employees and customers. Therefore it is offering cooperation within the framework of the outsourcing agreement to the companies working with textiles, paper, glass, wood, metal, and other such materials, universities and R&D institutions. Partners will be expected to provide samples of the materials. The company will, in turn, conduct their quantitative and qualitative evaluation, prepare the report and explain results. If requested, they can also advise on how to improve the antiviral and antibacterial properties of materials and final products.

Advantages & innovations

Cooperation plus value: 
- A unique method of assessing antiviral properties of materials - no other company nor any R&D institutions has developed and is offering this method of testing. - The offered tests are faster, cheaper and more accurate than the ones already available - the results and recommendation are available in 7 day. - Individual approach - as materials for tests differ one from the other, so thus the tests themself must be and are tailored to the specific situation and partners' needs. - The company not only tests antiviral properties of the supplied materials but can also help partner improve them, using its neural network to create a highly-effective mixture from the collection of over 900 phages with lytic potential. - The firm provides services tailored to partners' specific needs and requests.

Stage of development

Cooperation stage dev stage: 
Already on the market

Partner sought

Cooperation area: 
Type of Partner: industry (companies working with textiles, paper, glass, wood, metal, and other materials), universities and R&D institutions Role of Partner: Partner is expected to engage the company in its processes by delegating the tasks of testing materials for their antiviral properties. He also will have to supply materials for the tests.

Type and size

Cooperation task: 
SME 11-50,University,R&D Institution,SME <10,>500 MNE,251-500,SME 51-250,>500